{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:50:24Z","timestamp":1794037824591,"version":"4.8.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["206618\/Z\/17\/Z"],"award-info":[{"award-number":["206618\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/M012328\/2"],"award-info":[{"award-number":["MR\/M012328\/2"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Intramural Research Programs of the National Human Genome Research Institute"},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115142-2"],"award-info":[{"award-number":["115142-2"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["777357"],"award-info":[{"award-number":["777357"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115142-2"],"award-info":[{"award-number":["115142-2"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["777357"],"award-info":[{"award-number":["777357"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Regulatory B cells restrict immune and inflammatory responses across a number of contexts. This capacity is mediated primarily through the production of IL-10. Here we demonstrate that the induction of a regulatory program in human B cells is dependent on a metabolic priming event driven by cholesterol metabolism. Synthesis of the metabolic intermediate geranylgeranyl pyrophosphate (GGPP) is required to specifically drive IL-10 production, and to attenuate Th1 responses. Furthermore, GGPP-dependent protein modifications control signaling through PI3K\u03b4-AKT-GSK3, which in turn promote BLIMP1-dependent IL-10 production. Inherited gene mutations in cholesterol metabolism result in a severe autoinflammatory syndrome termed mevalonate kinase deficiency (MKD). Consistent with our findings, B cells from MKD patients induce poor IL-10 responses and are functionally impaired. Moreover, metabolic supplementation with GGPP is able to reverse this defect. Collectively, our data define cholesterol metabolism as an integral metabolic pathway for the optimal functioning of human IL-10 producing regulatory B cells.<\/jats:p>","DOI":"10.1038\/s41467-020-17179-4","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T06:03:03Z","timestamp":1594188183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0875-446X","authenticated-orcid":false,"given":"Jack A.","family":"Bibby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5271-4863","authenticated-orcid":false,"given":"Harriet A.","family":"Purvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hayday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9061-879X","authenticated-orcid":false,"given":"Anita","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9432-4051","authenticated-orcid":false,"given":"Klaus","family":"Okkenhaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2243-5315","authenticated-orcid":false,"given":"Sofia","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivona","family":"Aksentijevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen J.","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4196-1417","authenticated-orcid":false,"given":"Claudia","family":"Kemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0470-1827","authenticated-orcid":false,"given":"Andrew P.","family":"Cope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7802-0875","authenticated-orcid":false,"given":"Esperanza","family":"Perucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,8]]},"reference":[{"key":"17179_CR1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","volume":"42","author":"EC Rosser","year":"2015","unstructured":"Rosser, E. C. & Mauri, C. Regulatory B cells: origin, phenotype, and function. Immunity 42, 607\u2013612 (2015).","journal-title":"Immunity"},{"key":"17179_CR2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/intimm\/dxv046","volume":"27","author":"JM Lykken","year":"2015","unstructured":"Lykken, J. M., Candando, K. M. & Tedder, T. F. Regulatory B10 cell development and function. Int. Immunol. 27, 471\u2013477 (2015).","journal-title":"Int. Immunol."},{"key":"17179_CR3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.immuni.2018.06.007","volume":"49","author":"AC Lino","year":"2018","unstructured":"Lino, A. C. et al. LAG-3 inhibitory receptor expression identifies immunosuppressive natural regulatory plasma cells. Immunity 49, 120\u2013133 (2018).","journal-title":"Immunity"},{"key":"17179_CR4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cell.2018.11.035","volume":"176","author":"OL Rojas","year":"2019","unstructured":"Rojas, O. L. et al. Recirculating intestinal IgA-producing cells regulate neuroinflammation via IL-10. Cell 176, 610\u2013624 (2019).","journal-title":"Cell"},{"key":"17179_CR5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","volume":"32","author":"PA Blair","year":"2010","unstructured":"Blair, P. A. et al. CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 32, 129\u2013140 (2010).","journal-title":"Immunity"},{"key":"17179_CR6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","volume":"117","author":"Y Iwata","year":"2011","unstructured":"Iwata, Y. et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117, 530\u2013541 (2011).","journal-title":"Blood"},{"key":"17179_CR7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.20021293","volume":"197","author":"C Mauri","year":"2003","unstructured":"Mauri, C., Gray, D., Mushtaq, N. & Londei, M. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197, 489\u2013501 (2003).","journal-title":"J. Exp. Med."},{"key":"17179_CR8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature12979","volume":"507","author":"P Shen","year":"2014","unstructured":"Shen, P. et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507, 366\u2013370 (2014).","journal-title":"Nature"},{"key":"17179_CR9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature14395","volume":"521","author":"S Shalapour","year":"2015","unstructured":"Shalapour, S. et al. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature 521, 94\u201398 (2015).","journal-title":"Nature"},{"key":"17179_CR10","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1084\/jem.186.10.1749","volume":"186","author":"A Mizoguchi","year":"2002","unstructured":"Mizoguchi, A., Mizoguchi, E., Smith, R. N., Preffer, F. I. & Bhan, A. K. Suppressive role of B cells in chronic colitis of T cell receptor \u03b1 mutant mice. J. Exp. Med. 186, 1749\u20131756 (2002).","journal-title":"J. Exp. Med."},{"key":"17179_CR11","doi-asserted-by":"crossref","first-page":"173ra23","DOI":"10.1126\/scitranslmed.3005407","volume":"5","author":"F Flores-Borja","year":"2013","unstructured":"Flores-Borja, F. et al. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci. Transl. Med. 5, 173ra23 (2013).","journal-title":"Sci. Transl. Med."},{"key":"17179_CR12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.immuni.2016.02.012","volume":"44","author":"M Menon","year":"2016","unstructured":"Menon, M., Blair, P. A., Isenberg, D. A. & Mauri, C. A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus. Immunity 44, 683\u2013697 (2016).","journal-title":"Immunity"},{"key":"17179_CR13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nature11501","volume":"491","author":"A Yoshizaki","year":"2012","unstructured":"Yoshizaki, A. et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 491, 264\u2013268 (2012).","journal-title":"Nature"},{"key":"17179_CR14","doi-asserted-by":"publisher","unstructured":"Stark, A. K. et al. PI3K\u03b4 hyper-activation promotes development of B cells that exacerbate Streptococcus pneumoniae infection in an antibody-independent manner. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-018-05674-8 (2018).","DOI":"10.1038\/s41467-018-05674-8"},{"key":"17179_CR15","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/eji.201344341","volume":"44","author":"BS Liu","year":"2014","unstructured":"Liu, B. S., Cao, Y., Huizinga, T. W., Hafler, D. A. & Toes, R. E. M. TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells. Eur. J. Immunol. 44, 2121\u20132129 (2014).","journal-title":"Eur. J. Immunol."},{"key":"17179_CR16","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.cell.2017.04.004","volume":"169","author":"MD Buck","year":"2017","unstructured":"Buck, M. D., Sowell, R. T., Kaech, S. M. & Pearce, E. L. Cell 169, 570\u2013586 (2017).","journal-title":"Cell"},{"key":"17179_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41556-018-0217-x","volume":"21","author":"J Jung","year":"2019","unstructured":"Jung, J., Zeng, H. & Horng, T. Metabolism as a guiding force for immunity. Nat. Cell Biol. 21, 85\u201393, https:\/\/doi.org\/10.1038\/s41556-018-0217-x (2019).","journal-title":"Nat. Cell Biol."},{"key":"17179_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2018.07.005","author":"LR Waters","year":"2018","unstructured":"Waters, L. R., Ahsan, F. M., Wolf, D. M., Shirihai, O. & Teitell, M. A. Initial B cell activation induces metabolic reprogramming and mitochondrial remodeling. iScience https:\/\/doi.org\/10.1016\/j.isci.2018.07.005 (2018).","journal-title":"iScience"},{"key":"17179_CR19","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.4049\/jimmunol.1302062","volume":"192","author":"A Caro-Maldonado","year":"2014","unstructured":"Caro-Maldonado, A. et al. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J. Immunol. 192, 3626\u20133636 (2014).","journal-title":"J. Immunol."},{"key":"17179_CR20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ni.3664","volume":"18","author":"J Jellusova","year":"2017","unstructured":"Jellusova, J. et al. Gsk3 is a metabolic checkpoint regulator in B cells. Nat. Immunol. 18, 303\u2013312 (2017).","journal-title":"Nat. Immunol."},{"key":"17179_CR21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LAJ O\u2019Neill","year":"2016","unstructured":"O\u2019Neill, L. A. J., Kishton, R. J. & Rathmell, J. A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 16, 553\u2013565 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"17179_CR22","doi-asserted-by":"publisher","unstructured":"Perucha, E. et al. The cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cells. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-019-08332-9 (2019).","DOI":"10.1038\/s41467-019-08332-9"},{"key":"17179_CR23","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/ni.3487","volume":"17","author":"MK Akula","year":"2016","unstructured":"Akula, M. K. et al. Control of the innate immune response by the mevalonate pathway. Nat. Immunol. 17, 922\u2013929 (2016).","journal-title":"Nat. Immunol."},{"key":"17179_CR24","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1172\/JCI30868","volume":"117","author":"AKM Sjogren","year":"2007","unstructured":"Sjogren, A. K. M. et al. GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer. J. Clin. Invest. 117, 1294\u20131304 (2007).","journal-title":"J. Clin. Invest."},{"key":"17179_CR25","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/art.39763","volume":"68","author":"NM ter Haar","year":"2016","unstructured":"ter Haar, N. M. et al. The phenotype and genotype of mevalonate kinase deficiency: a series of 114 cases from the eurofever registry. Arthritis Rheumatol. 68, 2795\u20132805 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"17179_CR26","doi-asserted-by":"publisher","unstructured":"Favier, L. A. & Schulert, G. S. Mevalonate kinase deficiency: current perspectives. Appl. Clin. Genet. https:\/\/doi.org\/10.2147\/TACG.S93933 (2016).","DOI":"10.2147\/TACG.S93933"},{"key":"17179_CR27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrm.2015.11","volume":"17","author":"M Wang","year":"2016","unstructured":"Wang, M. & Casey, P. J. Protein prenylation: unique fats make their mark on biology. Nat. Rev. Mol. Cell Biol. 17, 110\u2013122 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"17179_CR28","doi-asserted-by":"publisher","unstructured":"Maurer-Stroh, S. et al. Towards complete sets of farnesylated and geranylgeranylated proteins. PLoS Comput. Biol. https:\/\/doi.org\/10.1371\/journal.pcbi.0030066 (2007).","DOI":"10.1371\/journal.pcbi.0030066"},{"key":"17179_CR29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni1221","volume":"6","author":"M Martin","year":"2005","unstructured":"Martin, M., Rehani, K., Jope, R. S. & Michalek, S. M. Toll-like receptor\u2014mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6, 777\u2013784 (2005).","journal-title":"Nat. Immunol."},{"key":"17179_CR30","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.cell.2018.01.029","volume":"172","author":"SA Lambert","year":"2018","unstructured":"Lambert, S. A. et al. The human transcription factors. Cell 172, 650\u2013665 (2018).","journal-title":"Cell"},{"key":"17179_CR31","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1093\/nar\/gky787","volume":"46","author":"SC Pro","year":"2018","unstructured":"Pro, S. C. et al. Global landscape of mouse and human cytokine transcriptional regulation. Nucleic Acids Res. 46, 9321\u20139337 (2018).","journal-title":"Nucleic Acids Res."},{"key":"17179_CR32","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/eji.201343822","volume":"44","author":"G Heine","year":"2014","unstructured":"Heine, G. et al. Autocrine IL-10 promotes human B-cell differentiation into IgM- or IgG-secreting plasmablasts. Eur. J. Immunol. 44, 1615\u20131621 (2014).","journal-title":"Eur. J. Immunol."},{"key":"17179_CR33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ni.3349","volume":"17","author":"M Minnich","year":"2016","unstructured":"Minnich, M. et al. Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation. Nat. Immunol. 17, 331\u2013343 (2016).","journal-title":"Nat. Immunol."},{"key":"17179_CR34","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/annrheumdis-2012-202082","volume":"72","author":"JE Balow","year":"2013","unstructured":"Balow, J. E. et al. Microarray-based gene expression profiling in patients with cryopyrin-associated periodic syndromes defines a disease-related signature and IL-1-responsive transcripts. Ann. Rheum. Dis. 72, 1064\u20131070 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"17179_CR35","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1182\/blood-2005-12-4788","volume":"107","author":"CA Doughty","year":"2006","unstructured":"Doughty, C. A. et al. Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 107, 4458\u20134465 (2006).","journal-title":"Blood"},{"key":"17179_CR36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nature12297","volume":"499","author":"H Zeng","year":"2013","unstructured":"Zeng, H. et al. MTORC1 couples immune signals and metabolic programming to establish Treg-cell function. Nature 499, 485\u2013490 (2013).","journal-title":"Nature"},{"key":"17179_CR37","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.4049\/jimmunol.1701703","volume":"202","author":"S Chellappa","year":"2019","unstructured":"Chellappa, S. et al. The PI3K p110\u03b4 isoform inhibitor idelalisib preferentially inhibits human regulatory T cell function. J. Immunol. 202, 1397\u20131405 (2019).","journal-title":"J. Immunol."},{"key":"17179_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-017-0641-0","author":"H Gbelcov\u00e1","year":"2017","unstructured":"Gbelcov\u00e1, H. et al. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells. Lipids Health Dis. https:\/\/doi.org\/10.1186\/s12944-017-0641-0 (2017).","journal-title":"Lipids Health Dis."},{"key":"17179_CR39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbrc.2010.05.045","volume":"397","author":"BR Ali","year":"2010","unstructured":"Ali, B. R., Nouvel, I., Leung, K. F., Hume, A. N. & Seabra, M. C. A novel statin-mediated \u2018prenylation block-and-release\u2019 assay provides insight into the membrane targeting mechanisms of small GTPases. Biochem. Biophys. Res. Commun. 397, 34\u201341 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"17179_CR40","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1172\/JCI43758","volume":"121","author":"OM Khan","year":"2011","unstructured":"Khan, O. M. et al. Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice. J. Clin. Invest. 121, 628\u2013639 (2011).","journal-title":"J. Clin. Invest."},{"key":"17179_CR41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1172\/JCI80997","volume":"126","author":"R L\u00f3pez-Posadas","year":"2016","unstructured":"L\u00f3pez-Posadas, R. et al. Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation. J. Clin. Invest. 126, 611\u2013626 (2016).","journal-title":"J. Clin. Invest."},{"key":"17179_CR42","doi-asserted-by":"publisher","unstructured":"Lighaam, L. C. et al. In vitro-induced human IL-10+ B cells do not show a subset-defining marker signature and plastically co-express IL-10 with pro-inflammatory cytokines. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.01913 (2018).","DOI":"10.3389\/fimmu.2018.01913"},{"key":"17179_CR43","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.molimm.2009.03.010","volume":"46","author":"N Dil","year":"2009","unstructured":"Dil, N. & Marshall, A. J. Role of phosphoinositide 3-kinase p110\u03b4 in TLR4- and TLR9-mediated B cell cytokine production and differentiation. Mol. Immunol. 46, 1970\u20131978 (2009).","journal-title":"Mol. Immunol."},{"key":"17179_CR44","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/eji.200838801","volume":"39","author":"PR Kramer","year":"2009","unstructured":"Kramer, P. R., Winger, V. & Reuben, J. PI3K limits TNF-\u03b1 production in CD16-activated monocytes. Eur. J. Immunol. 39, 561\u2013570 (2009).","journal-title":"Eur. J. Immunol."},{"key":"17179_CR45","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ni825","volume":"3","author":"T Fukao","year":"2002","unstructured":"Fukao, T. et al. P13K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 3, 875\u2013881 (2002).","journal-title":"Nat. Immunol."},{"key":"17179_CR46","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/eji.201444661","volume":"45","author":"EV Hill","year":"2015","unstructured":"Hill, E. V. et al. Glycogen synthase kinase-3 controls IL-10 expression in CD4+ effector T-cell subsets through epigenetic modification of the IL-10 promoter. Eur. J. Immunol. 45, 1103\u20131115 (2015).","journal-title":"Eur. J. Immunol."},{"key":"17179_CR47","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1084\/jem.20131548","volume":"211","author":"C Neumann","year":"2014","unstructured":"Neumann, C. et al. Role of Blimp-1 in programing Th effector cells into IL-10 producers. J. Exp. Med. 211, 1807\u20131819 (2014).","journal-title":"J. Exp. Med."},{"key":"17179_CR48","doi-asserted-by":"publisher","unstructured":"Wang, Y. H. et al. Blimp-1 contributes to the development and function of regulatory B cells. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.01909 (2019).","DOI":"10.3389\/fimmu.2019.01909"},{"key":"17179_CR49","doi-asserted-by":"publisher","unstructured":"Alexander, L. E. M. M. et al. Selective expression of the transcription elongation factor ELL3 in B cells prior to ELL2 drives proliferation and survival. Mol. Immunol. https:\/\/doi.org\/10.1016\/j.molimm.2017.08.016 (2017).","DOI":"10.1016\/j.molimm.2017.08.016"},{"key":"17179_CR50","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.3554","volume":"20","author":"R-X Wang","year":"2014","unstructured":"Wang, R.-X. et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat. Med. 20, 633\u2013641 (2014).","journal-title":"Nat. Med."},{"key":"17179_CR51","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.immuni.2014.10.016","volume":"41","author":"M Matsumoto","year":"2014","unstructured":"Matsumoto, M. et al. Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity 41, 1040\u20131051 (2014).","journal-title":"Immunity"},{"key":"17179_CR52","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","volume":"49","author":"SA Jenks","year":"2018","unstructured":"Jenks, S. A. et al. Distinct effector B cells induced by unregulated Toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity 49, 725\u2013739 (2018).","journal-title":"Immunity"},{"key":"17179_CR53","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jaci.2017.02.033","volume":"140","author":"MA Munoz","year":"2017","unstructured":"Munoz, M. A. et al. Defective protein prenylation is a diagnostic biomarker of mevalonate kinase deficiency. J. Allergy Clin. Immunol. 140, 873\u2013875 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"17179_CR54","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/ni.3457","volume":"17","author":"YH Park","year":"2016","unstructured":"Park, Y. H., Wood, G., Kastner, D. L. & Chae, J. J. Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat. Immunol. 17, 914\u2013921 (2016).","journal-title":"Nat. Immunol."},{"key":"17179_CR55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cell.2017.11.025","volume":"172","author":"S Bekkering","year":"2018","unstructured":"Bekkering, S. et al. Metabolic induction of trained immunity through the mevalonate pathway. Cell 172, 135\u2013146 (2018).","journal-title":"Cell"},{"key":"17179_CR56","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/s41423-019-0227-z","volume":"16","author":"X Lin","year":"2019","unstructured":"Lin, X. et al. IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sj\u00f6gren\u2019s syndrome. Cell. Mol. Immunol. 16, 921\u2013931 (2019).","journal-title":"Cell. Mol. Immunol."},{"key":"17179_CR57","doi-asserted-by":"publisher","unstructured":"Lal, G. et al. IL-10 from marginal zone precursor B cells controls the differentiation of Th17, Tfh and Tfr cells in transplantation tolerance. Immunol. Lett. https:\/\/doi.org\/10.1016\/j.imlet.2016.01.002 (2016).","DOI":"10.1016\/j.imlet.2016.01.002"},{"key":"17179_CR58","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.1073560","volume":"297","author":"K Okkenhaug","year":"2002","unstructured":"Okkenhaug, K. et al. Impaired B and T cell antigen receptor signaling in p110\u03b4 PI 3-kinase mutant mice. Science 297, 1031\u20131034 (2002).","journal-title":"Science"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17179-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17179-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17179-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T19:00:25Z","timestamp":1670266825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17179-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,8]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["17179"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-17179-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.01.03.893982","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,8]]},"assertion":[{"value":"15 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3412"}}